These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 8955938)

  • 1. Nitric oxide synthase inhibitors attenuate acute and chronic morphine withdrawal response in the rat locus coeruleus: an in vivo voltammetric study.
    Hall S; Milne B; Jhamandas K
    Brain Res; 1996 Nov; 739(1-2):182-91. PubMed ID: 8955938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Excitatory action of N-methyl-D-aspartate on the rat locus coeruleus is mediated by nitric oxide: an in vivo voltammetric study.
    Hall S; Milne B; Jhamandas K
    Brain Res; 1998 Jun; 796(1-2):176-86. PubMed ID: 9689468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of acute and chronic opioid withdrawal by a selective soluble guanylyl cyclase inhibitor.
    Sullivan ME; Hall SR; Milne B; Jhamandas K
    Brain Res; 2000 Mar; 859(1):45-56. PubMed ID: 10720614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for the involvement of excitatory amino acid pathways in the development of precipitated withdrawal from acute and chronic morphine: an in vivo voltammetric study in the rat locus coeruleus.
    Hong M; Milne B; Jhamandas K
    Brain Res; 1993 Sep; 623(1):131-41. PubMed ID: 8221081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Attenuation of withdrawal-induced hyperactivity of locus coeruleus neurones by inhibitors of nitric oxide synthase in morphine-dependent rats.
    Pineda J; Torrecilla M; Martín-Ruiz R; Ugedo L
    Neuropharmacology; 1998 Jun; 37(6):759-67. PubMed ID: 9707290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of excitatory amino acid pathways in the expression of precipitated opioid withdrawal in the rostral ventrolateral medulla: an in vivo voltammetric study.
    Wang L; Milne B; Jhamandas K
    Brain Res; 1995 Oct; 697(1-2):130-42. PubMed ID: 8593569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local opiate withdrawal in locus coeruleus neurons in vitro.
    Ivanov A; Aston-Jones G
    J Neurophysiol; 2001 Jun; 85(6):2388-97. PubMed ID: 11387385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring nitric oxide (NO) in rat locus coeruleus: differential effects of NO synthase inhibitors.
    Desvignes C; Robert F; Vachette C; Chouvet G; Cespuglio R; Renaud B; Lambás-Señas L
    Neuroreport; 1997 Apr; 8(6):1321-5. PubMed ID: 9172128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Further in vivo studies on attenuating morphine withdrawal: isoform-selective nitric oxide synthase inhibitors differ in efficacy.
    Vaupel DB; Kimes AS; London ED
    Eur J Pharmacol; 1997 Apr; 324(1):11-20. PubMed ID: 9137908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NO synthase inhibitors attenuate locus coeruleus catecholamine metabolism and behavior induced by morphine withdrawal.
    Javelle N; Bérod A; Renaud B; Lambás-Señas L
    Neuroreport; 2002 Apr; 13(5):725-8. PubMed ID: 11973478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the morphine withdrawal syndrome by a nitric oxide synthase inhibitor, NG-nitro-L-arginine methyl ester.
    Adams ML; Kalicki JM; Meyer ER; Cicero TJ
    Life Sci; 1993; 52(22):PL245-9. PubMed ID: 7684108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Naltrexone-precipitated morphine withdrawal in infant rat is attenuated by acute administration of NOS inhibitors but not NMDA receptor antagonists.
    Zhu H; Barr GA
    Psychopharmacology (Berl); 2000 Jun; 150(3):325-36. PubMed ID: 10923761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spinal NMDA receptor--nitric oxide mediation of the expression of morphine withdrawal symptoms in the rat.
    Buccafusco JJ; Terry AV; Shuster L
    Brain Res; 1995 May; 679(2):189-99. PubMed ID: 7633880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible involvement of the locus coeruleus in inhibition by prostanoid EP(3) receptor-selective agonists of morphine withdrawal syndrome in rats.
    Nakagawa T; Masuda T; Watanabe T; Minami M; Satoh M
    Eur J Pharmacol; 2000 Mar; 390(3):257-66. PubMed ID: 10708732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of agmatine on locus coeruleus neuron activity: possible involvement of nitric oxide.
    Ruiz-Durántez E; Ruiz-Ortega JA; Pineda J; Ugedo L
    Br J Pharmacol; 2002 Mar; 135(5):1152-8. PubMed ID: 11877321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of excitatory amino acids in the expression of precipitated acute and chronic clonidine withdrawal: an in vivo voltammetric study in the rat locus coeruleus.
    Duggan S; Hong M; Milne B; Jhamandas K
    Brain Res; 1994 Dec; 665(2):253-61. PubMed ID: 7895061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of nitric oxide in morphine dependence and withdrawal excitation of rat oxytocin neurons.
    Bull PM; Ludwig M; Blackburn-Munro GJ; Delgado-Cohen H; Brown CH; Russell JA
    Eur J Neurosci; 2003 Nov; 18(9):2545-51. PubMed ID: 14622155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ng-nitro-L-arginine, an NOS inhibitor, reduces tolerance to morphine in the rat locus coeruleus.
    Highfield DA; Grant S
    Synapse; 1998 Jul; 29(3):233-9. PubMed ID: 9635893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric oxide synthase inhibitors. Preclinical studies of potential use for treatment of opioid withdrawal.
    Vaupel DB; Kimes AS; London ED
    Neuropsychopharmacology; 1995 Dec; 13(4):315-22. PubMed ID: 8747756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of simultaneous administration of alpha(2) -adrenergic agents with L-NAME or L-arginine on the development and expression of morphine dependence in mice.
    Zarrindast MR; Homayoun H; Khavandgar S; Fayaz-Dastgerdi M; Fayaz-Dastgerdi M
    Behav Pharmacol; 2002 Mar; 13(2):117-25. PubMed ID: 11981224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.